AC Immune SA (ACIU): Price and Financial Metrics
ACIU Price/Volume Stats
| Current price | $2.68 | 52-week high | $5.14 |
| Prev. close | $2.70 | 52-week low | $2.25 |
| Day low | $2.63 | Volume | 235,900 |
| Day high | $2.77 | Avg. volume | 323,414 |
| 50-day MA | $3.13 | Dividend yield | N/A |
| 200-day MA | $3.32 | Market Cap | 265.16M |
ACIU Stock Price Chart Interactive Chart >
AC Immune SA (ACIU) Company Bio
AC Immune SA, a clinical stage Swiss-based biopharmaceutical company, focuses on neurodegenerative diseases with three product candidates in clinical trials. It designs, discovers, and develops therapeutic and diagnostic products intended to prevent and modify diseases caused by mis-folding proteins. The company was founded in 2003 and is based in Lausanne, Switzerland.
ACIU Price Returns
| 1-mo | -18.54% |
| 3-mo | -27.37% |
| 6-mo | -35.42% |
| 1-year | -38.11% |
| 3-year | -48.36% |
| 5-year | -67.32% |
| YTD | -46.40% |
| 2023 | 145.10% |
| 2022 | -58.79% |
| 2021 | -4.26% |
| 2020 | -39.32% |
| 2019 | -9.84% |
Continue Researching ACIU
Want to see what other sources are saying about AC Immune SA's financials and stock price? Try the links below:AC Immune SA (ACIU) Stock Price | Nasdaq
AC Immune SA (ACIU) Stock Quote, History and News - Yahoo Finance
AC Immune SA (ACIU) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...